Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

Edwards, Michaela Jane and Gallagher, A. and Nair, Parameswaran and Drew, Stewart and Vyas, Aashish and Sharma, R and Marsden, Paul and Evans, David John William (2018) Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews (1). ISSN 1469-493X

[img]
Preview
PDF (Edwards_et_al-2018-)
Edwards_et_al_2018_.pdf - Published Version
Available under License Creative Commons Attribution-NonCommercial.

Download (212kB)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.

Item Type:
Journal Article
Journal or Publication Title:
Cochrane Database of Systematic Reviews
Additional Information:
This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700
Subjects:
ID Code:
90075
Deposited By:
Deposited On:
31 Jan 2018 09:54
Refereed?:
Yes
Published?:
Published
Last Modified:
05 Apr 2020 04:50